• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

TAVR With Evolut: Interim Results Promising in Low-Risk Patients TAVR With Evolut: Interim Results Promising in Low-Risk Patients
The transcatheter procedure was noninferior to surgery in an interim Bayesian analysis of the primary endpoint -- death from any cause or disabling stroke at 24 months -- in a new trial involving patients with severe aortic stenosis at low surgical risk.Medscape Medical News
Source: Medscape Medical News Headlines - March 16, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

PARTNER 3: TAVR Success in Low-Risk Patients PARTNER 3: TAVR Success in Low-Risk Patients
The procedure using the SAPIEN 3 valve showed a significantly lower rate of death, stroke, and rehospitalization at 1 year vs surgery in patients with severe aortic stenosis at low surgical risk.Medscape Medical News
Source: Medscape Medical News Headlines - March 16, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Survival and Stroke Similar for TAVR and SAVR at 5 Years Survival and Stroke Similar for TAVR and SAVR at 5 Years
The early mortality benefit seen with transcatheter aortic valve replacement over surgical repair in patients with severe aortic stenosis at high surgical risk is no longer significant at 5 years.Medscape Medical News
Source: Medscape Medical News Headlines - November 26, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

NOTION: 5-Year TAVR vs SAVR Outcomes Similar in Low-Risk Patients NOTION: 5-Year TAVR vs SAVR Outcomes Similar in Low-Risk Patients
All-cause mortality, MI, and stroke were similar in low-risk patients with severe aortic stenosis who had transcatheter aortic valve replacement and those who had surgery, but 42% of TAVR patients needed pacemakers.Medscape Medical News
Source: Medscape Medical News Headlines - April 9, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

CoreValve High-Risk Study at 3 Years: TAVR Advantage SustainedCoreValve High-Risk Study at 3 Years: TAVR Advantage Sustained
In this high-risk population with severe aortic stenosis, patients were less likely to die or have a stroke within 3 years if they had percutaneous rather than surgical valve replacement. Heartwire from Medscape
Source: Medscape Medical News Headlines - April 15, 2016 Category: Consumer Health News Tags: Cardiology News Source Type: news